arrow
C

Christina Bergmann

University Hospital Erlangen
H指数:28
被引数:4,448

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Proton pump inhibitor use and long-term outcomes in systemic sclerosis: a real-life analysis from the EUSTAR database

质子泵抑制剂使用与系统性硬化症长期结局:来自EUSTAR数据库的真实世界分析

2026-09-180
OAAI
Effectiveness of oral anticoagulants in precapillary pulmonary hypertension associated with systemic sclerosis: a EUSTAR cohort study

系统性硬化症相关肺动脉高压患者口服抗凝剂的有效性:一项EUSTAR队列研究

2026-09-180
OAAI
Real-World Safety and Effectiveness of JAK Inhibitors in Systemic Sclerosis: A Propensity-Matched Study From the EUSTAR Cohort

系统性硬化症中JAK抑制剂的实时安全性和有效性:来自EUSTAR队列的倾向性匹配研究

2026-09-080
OAAI
Advances in imaging for systemic sclerosis

系统性硬化症影像学进展

2026-07-310
PRE
The nuclear receptor TR4 orchestrates cytoskeletal organization in a Gα12/ROCK-dependent manner to promote myofibroblast differentiation and tissue fibrosis in systemic sclerosis

核受体TR4通过Gα12/ROCK依赖方式调控细胞骨架组织,以促进系统性硬化症中的肌成纤维细胞分化和组织纤维化

2026-05-280
OAAI
Deep phenotyping of skin tissue remodeling in patients with systemic sclerosis treated with CD19-CAR T cells

系统性硬化症患者经CD19-CAR T细胞治疗后皮肤组织重塑的深度表型分析

2026-05-230
OAAI
CD19 CAR-T cells for treatment-refractory autoimmune diseases: the phase 1/2 CASTLE basket trial

CD19 CAR-T细胞治疗难治性自身免疫性疾病:CASTLE篮式试验的1/2期研究

2026-01-070
OAAI
BCMA T-Cell Engager Therapy in Patients with Refractory Autoimmune Disease

BCMA T细胞结合疗法在难治性自身免疫性疾病患者中的应用

2025-10-164
PRE
Local immune effector cell-associated toxicity syndrome in CAR T-cell treated patients with refractory systemic lupus erythematosus – Authors' reply

局部免疫效应细胞相关毒性综合征在难治性系统性红斑狼疮CAR T细胞治疗患者中的应用——作者回复

2025-08-120
PRE
Local immune effector cell-associated toxicity syndrome in CAR T-cell treated patients with autoimmune disease: an observational study

自身免疫病患者CAR T细胞治疗相关的局部免疫效应细胞相关毒性综合征:一项观察性研究

2025-04-300
OAAI
Evaluation of Systemic Sclerosis Primary Heart Involvement and Chronic Heart Failure in the European Scleroderma Trials and Research Cohort

欧洲硬皮病试验与研究队列中系统性硬化症原发性心脏受累及慢性心力衰竭的评估

2025-02-260
OAAI
Gastroesophageal reflux disease is associated with a more severe interstitial lung disease in systemic sclerosis in the EUSTAR cohort

胃食管反流病与EUSTAR队列中系统性硬化症患者更严重的间质性肺疾病相关。

2025-01-080
PRE
Exploring CAR T-Cell Dynamics: Balancing Potent Cytotoxicity and Controlled Inflammation in CAR T-Cells Derived from Systemic Sclerosis and Myositis Patients

探索CAR T细胞动力学:平衡来自系统性硬化症和肌炎患者的CAR T细胞的强大细胞毒性及可控炎症

2025-01-080
OA
Mutual Amplification of GLI2/Hedgehog and Transcription Factor JUN/AP-1 Signaling in Fibroblasts in Systemic Sclerosis: Potential Implications for Combined Therapies
2024-10-200
OAAI
Diffusing Capacity of the Lungs for Carbon Monoxide and Echocardiographic Parameters in Identifying Mild Pulmonary Hypertension in the EUSTAR Cohort of Patients With Systemic Sclerosis

在系统性硬化症患者的EUSTAR队列中,一氧化碳和超声心动图参数的肺扩散能力可识别轻度肺动脉高压

CHEST
IF8.6
2024-10-012
OAAI
Diagnostic Accuracy of a Mobile AI-Based Symptom Checker anda Web-Based Self-Referral Tool in Rheumatology: Multicenter Randomized Controlled Trial

基于移动AI的症状检查器和基于Web的自我推荐工具在风湿病中的诊断准确性: 多中心随机对照试验

2024-07-231
OAAI
EFFICACY OF CD19-TARGETING CAR T CELL TREATMENT IN PATIENTS WITH DIFFUSE SYSTEMIC SCLEROSIS (dSSc) - AN OPEN LABEL, SINGLE-CENTER PILOT STUDY

CD19靶向CAR T细胞治疗在弥漫性系统性硬化症(dSSc)患者中的疗效——一项开放标签、单中心试点研究

2024-06-010
PRE
Noncanonical WNT5A controls the activation of latent TGF- β to drive fibroblast activation and tissue fibrosis
2024-03-262
OAAI